Evanthia Lalla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Evanthia Lalla has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Panos N. Papapanou
Division of Periodontics, Section of Oral, Diagnostic and Rehabilitation Sciences, College of Dental Medicine Columbia University New York New York USA
11 shared publications Ira B. Lamster
8 shared publicationsAnn Marie Schmidt
New York University School of Medicine, New York, New York
6 shared publications- Georg Alexander Roth
Department of Anesthesiology, General Intensive Care and Pain Medicine, Medical University of Vienna, Vienna, Austria; RAIC Laboratory 13C1, Medical University of Vienna, Vienna, Austria
6 shared publications B. Cheng
Department of Biostatistics, Mailman School of Public Health, Columbia University, 630 W. 168th Street, PH7E-110, New York, NY 10032, USA
3 shared publicationsBin Cheng
Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY
3 shared publications
Latest Publications
- 1 October 2012
- Published by Elsevier in Dental Clinics of North America
- Vol. 56 (4) , 819-829
Assessment and Management of Patients with Diabetes Mellitus in the Dental Office
- 1 October 2012
- Published by Elsevier in Dental Clinics of North America
- Vol. 56 (4) , 819-829
Assessment and Management of Patients with Diabetes Mellitus in the Dental Office
- Open Access
- 12 March 2012
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1255 (1) , 1-15
Diabetes and oral disease: implications for health professionals
“Diabetes and Oral Disease: Implications for Health Professionals” was a one‐day conference convened by the Columbia University College of Dental Medicine, the Columbia University College of Physicians and Surgeons, and the New York Academy of Sciences on May 4, 2011 in New York City. The program included an examination of the bidirectional relationship between oral disease and diabetes and the interprofessional working relationships for the care of people who have diabetes. The overall goal of the conference was to promote discussion among the healthcare professions who treat people with diabetes, encourage improved communication and collaboration among them, and, ultimately, improve patient management of the oral and overall effects of diabetes. Attracting over 150 members of the medical and dental professions from eight different countries, the conference included speakers from academia and government and was divided into four sessions. This report summarizes the scientific presentations of the event.a
- 12 March 2012
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1255 (1) , 1-15
Open AccessDiabetes and oral disease: implications for health professionals
“Diabetes and Oral Disease: Implications for Health Professionals” was a one‐day conference convened by the Columbia University College of Dental Medicine, the Columbia University College of Physicians and Surgeons, and the New York Academy of Sciences on May 4, 2011 in New York City. The program included an examination of the bidirectional relationship between oral disease and diabetes and the interprofessional working relationships for the care of people who have diabetes. The overall goal of the conference was to promote discussion among the healthcare professions who treat people with diabetes, encourage improved communication and collaboration among them, and, ultimately, improve patient management of the oral and overall effects of diabetes. Attracting over 150 members of the medical and dental professions from eight different countries, the conference included speakers from academia and government and was divided into four sessions. This report summarizes the scientific presentations of the event.a
- Top Cited Papers
- 28 June 2011
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 7 (12) , 738-748
Diabetes mellitus and periodontitis: a tale of two common interrelated diseases
Diabetes mellitus (a group of metabolic disorders characterized by hyperglycemia) and periodontitis (a microbially induced inflammatory disorder that affects the supporting structures of teeth) are both common, chronic conditions. Multiple studies have demonstrated that diabetes mellitus (type 1 and type 2) is an established risk factor for periodontitis. Findings from mechanistic studies indicate that diabetes mellitus leads to a hyperinflammatory response to the periodontal microbiota and also impairs resolution of inflammation and repair, which leads to accelerated periodontal destruction. The cell surface receptor for advanced glycation end products and its ligands are expressed in the periodontium of individuals with diabetes mellitus and seem to mediate these processes. The association between the two diseases is bidirectional, as periodontitis has been reported to adversely affect glycemic control in patients with diabetes mellitus and to contribute to the development of diabetic complications. In addition, meta-analyses conclude that periodontal therapy in individuals with diabetes mellitus can result in a modest improvement of glycemic control. The effect of periodontal infections on diabetes mellitus is potentially explained by the resulting increase in levels of systemic proinflammatory mediators, which exacerbates insulin resistance. As our understanding of the relationship between diabetes mellitus and periodontitis deepens, increased patient awareness of the link between diabetes mellitus and oral health and collaboration among medical and dental professionals for the management of affected individuals become increasingly important.
- 28 June 2011
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 7 (12) , 738-748
Top Cited PapersDiabetes mellitus and periodontitis: a tale of two common interrelated diseases
Diabetes mellitus (a group of metabolic disorders characterized by hyperglycemia) and periodontitis (a microbially induced inflammatory disorder that affects the supporting structures of teeth) are both common, chronic conditions. Multiple studies have demonstrated that diabetes mellitus (type 1 and type 2) is an established risk factor for periodontitis. Findings from mechanistic studies indicate that diabetes mellitus leads to a hyperinflammatory response to the periodontal microbiota and also impairs resolution of inflammation and repair, which leads to accelerated periodontal destruction. The cell surface receptor for advanced glycation end products and its ligands are expressed in the periodontium of individuals with diabetes mellitus and seem to mediate these processes. The association between the two diseases is bidirectional, as periodontitis has been reported to adversely affect glycemic control in patients with diabetes mellitus and to contribute to the development of diabetic complications. In addition, meta-analyses conclude that periodontal therapy in individuals with diabetes mellitus can result in a modest improvement of glycemic control. The effect of periodontal infections on diabetes mellitus is potentially explained by the resulting increase in levels of systemic proinflammatory mediators, which exacerbates insulin resistance. As our understanding of the relationship between diabetes mellitus and periodontitis deepens, increased patient awareness of the link between diabetes mellitus and oral health and collaboration among medical and dental professionals for the management of affected individuals become increasingly important.
- 29 April 2011
- Published by SAGE Publications in Journal of Dental Research
- Vol. 90 (7) , 855-860
Identification of Unrecognized Diabetes and Pre-diabetes in a Dental Setting
Many diabetic patients remain undiagnosed, and oral findings may offer an unrealized opportunity for the identification of affected individuals unaware of their condition. We recruited 601 individuals who presented for care at a dental clinic, were ≥ 40 years old, if non-Hispanic white, and ≥ 30 years old, if Hispanic or non-white, and had never been told they have pre-diabetes or diabetes. Those with at least one self-reported diabetes risk factor (N = 535) received a periodontal examination and a point-of-care hemoglobin A1c (HbA1c) test. A fasting plasma glucose (FPG) test was used as the study outcome, signifying potential diabetes or pre-diabetes. Performance characteristics of simple models of dysglycemia (FPG ≥ 100 mg/dL) identification were evaluated and optimal cut-offs identified. A model including only two dental variables had an estimated area under the receiver operating characteristic curve (AUC) of 0.65. The addition of a point-of-care HbA1c test improved the AUC to 0.79 (p < 0.001). The presence of ≥ 26% deep pockets or ≥ 4 missing teeth correctly identified 73% of true cases; the addition of an HbA1c ≥ 5.7% increased correct identification to 92%. Analysis of our data suggests that oral healthcare professionals have the opportunity to identify unrecognized diabetes and pre-diabetes in dental patients and refer them to a physician for further evaluation and care.
- 29 April 2011
- Published by SAGE Publications in Journal of Dental Research
- Vol. 90 (7) , 855-860
Identification of Unrecognized Diabetes and Pre-diabetes in a Dental Setting
Many diabetic patients remain undiagnosed, and oral findings may offer an unrealized opportunity for the identification of affected individuals unaware of their condition. We recruited 601 individuals who presented for care at a dental clinic, were ≥ 40 years old, if non-Hispanic white, and ≥ 30 years old, if Hispanic or non-white, and had never been told they have pre-diabetes or diabetes. Those with at least one self-reported diabetes risk factor (N = 535) received a periodontal examination and a point-of-care hemoglobin A1c (HbA1c) test. A fasting plasma glucose (FPG) test was used as the study outcome, signifying potential diabetes or pre-diabetes. Performance characteristics of simple models of dysglycemia (FPG ≥ 100 mg/dL) identification were evaluated and optimal cut-offs identified. A model including only two dental variables had an estimated area under the receiver operating characteristic curve (AUC) of 0.65. The addition of a point-of-care HbA1c test improved the AUC to 0.79 (p < 0.001). The presence of ≥ 26% deep pockets or ≥ 4 missing teeth correctly identified 73% of true cases; the addition of an HbA1c ≥ 5.7% increased correct identification to 92%. Analysis of our data suggests that oral healthcare professionals have the opportunity to identify unrecognized diabetes and pre-diabetes in dental patients and refer them to a physician for further evaluation and care.
- 1 October 2010
- Published by Elsevier in Atherosclerosis
- Vol. 212 (2) , 451-456
Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells
- 1 October 2010
- Published by Elsevier in Atherosclerosis
- Vol. 212 (2) , 451-456
Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells
- 1 April 2010
- Published by Wiley in Journal of Periodontal Research
- Vol. 45 (2) , 239-245
Enhanced monocyte migration and pro-inflammatory cytokine production byPorphyromonas gingivalisinfection
Porphyromonas gingivalis, a major periodontal pathogen, has been reported to be involved in atherogenesis. In order to further understand this pathogen's link with systemic inflammation and vascular disease, we investigated its influence on murine monocytes and macrophages from three different sources. Concanavalin A-elicited peritoneal macrophages, peripheral blood monocyte-derived macrophages and WEHI 274.1 monocytes were infected with either P. gingivalis 381 or its non-invasive fimbriae-deficient mutant, DPG3. Infection with P. gingivalis 381 markedly induced monocyte migration and significantly enhanced production of the pro-inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6. Consistent with a role for this pathogen's major fimbriae and/or its invasive capacity, infection with DPG3 had a minimal effect on both monocyte attraction and pro-inflammatory cytokine production. Since monocyte recruitment and activation are important steps in the development of vascular inflammation and atherosclerosis, these results suggest that P. gingivalis infection may be involved in these processes.
- 1 April 2010
- Published by Wiley in Journal of Periodontal Research
- Vol. 45 (2) , 239-245
Enhanced monocyte migration and pro-inflammatory cytokine production byPorphyromonas gingivalisinfection
Porphyromonas gingivalis, a major periodontal pathogen, has been reported to be involved in atherogenesis. In order to further understand this pathogen's link with systemic inflammation and vascular disease, we investigated its influence on murine monocytes and macrophages from three different sources. Concanavalin A-elicited peritoneal macrophages, peripheral blood monocyte-derived macrophages and WEHI 274.1 monocytes were infected with either P. gingivalis 381 or its non-invasive fimbriae-deficient mutant, DPG3. Infection with P. gingivalis 381 markedly induced monocyte migration and significantly enhanced production of the pro-inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6. Consistent with a role for this pathogen's major fimbriae and/or its invasive capacity, infection with DPG3 had a minimal effect on both monocyte attraction and pro-inflammatory cytokine production. Since monocyte recruitment and activation are important steps in the development of vascular inflammation and atherosclerosis, these results suggest that P. gingivalis infection may be involved in these processes.
- 31 March 2009
- Published by Elsevier in Thrombosis Research
- Vol. 123 (5) , 780-784
Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells
- 31 March 2009
- Published by Elsevier in Thrombosis Research
- Vol. 123 (5) , 780-784
Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells
- Open Access
- 1 September 2008
- Published by American Public Health Association in American Journal of Public Health
- Vol. 98 (9) , S91-S94
Oral Disease Burden in Northern Manhattan Patients With Diabetes Mellitus
Objectives. We explored the association between diabetes mellitus and oral disease in a low-socioeconomic-status urban population. Methods. Dental records of 150 adults with diabetes and 150 nondiabetic controls from the dental clinic at Columbia University in Northern Manhattan matched by age and gender were studied. Results. There was a 50% increase in alveolar bone loss in diabetic patients compared with nondiabetic controls. Diabetes, increasing age, male gender, and use of tobacco products had a statistically significant effect on bone loss. Conclusions. Our findings provide evidence that diabetes is an added risk for oral disease in this low-income, underserved population of Northern Manhattan. Oral disease prevention and treatment programs may need to be part of the standards of continuing care for patients with diabetes
- 1 September 2008
- Published by American Public Health Association in American Journal of Public Health
- Vol. 98 (9) , S91-S94
Open AccessOral Disease Burden in Northern Manhattan Patients With Diabetes Mellitus
Objectives. We explored the association between diabetes mellitus and oral disease in a low-socioeconomic-status urban population. Methods. Dental records of 150 adults with diabetes and 150 nondiabetic controls from the dental clinic at Columbia University in Northern Manhattan matched by age and gender were studied. Results. There was a 50% increase in alveolar bone loss in diabetic patients compared with nondiabetic controls. Diabetes, increasing age, male gender, and use of tobacco products had a statistically significant effect on bone loss. Conclusions. Our findings provide evidence that diabetes is an added risk for oral disease in this low-income, underserved population of Northern Manhattan. Oral disease prevention and treatment programs may need to be part of the standards of continuing care for patients with diabetes
- Open Access
- 1 July 2007
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 272 (1) , 106-113
Porphyromonas gingivalisinfection and cell death in human aortic endothelial cells
Porphyromonas gingivalis is a periodontal pathogen that promotes a proatherogenic response in endothelial cells. Cell death responses of human aortic
- 1 July 2007
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 272 (1) , 106-113
Open AccessPorphyromonas gingivalisinfection and cell death in human aortic endothelial cells
Porphyromonas gingivalis is a periodontal pathogen that promotes a proatherogenic response in endothelial cells. Cell death responses of human aortic
- 19 April 2007
- Published by Wiley in Journal of Periodontal Research
- Vol. 42 (3) , 274-282
Effects of periodontal therapy on serum C‐reactive protein, sE‐selectin, and tumor necrosis factor‐α secretion by peripheral blood‐derived macrophages in diabetes. A pilot study
Background and Objective: Diabetes is associated with an increased risk for vascular disease and periodontitis. The aim of this study was to assess the effects of periodontal treatment in diabetes with respect to alterations in the pro‐inflammatory potential of peripheral blood mononuclear cells.Material and Methods: Ten patients with diabetes and moderate to severe periodontitis received full‐mouth subgingival debridement. Blood samples for serum/plasma and mononuclear cell isolation were collected prior to and 4 wk after therapy. Mononuclear cells were analyzed by flow cytometry and stimulated with lipopolysaccharide or ionomycin/phorbol ester to determine the pro‐inflammatory capacity of macrophages and lymphocytes, respectively.Results: Following periodontal treatment, all patients demonstrated a significant improvement in clinical periodontal status (p < 0.05), despite only modest reduction in subgingival bacterial load or homologous serum immunoglobulin G titers. CD14+ blood monocytes decreased by 47% (p < 0.05), and the percentage of macrophages spontaneously releasing tumor necrosis factor‐α decreased by 78% (p < 0.05). There were no significant changes in the capacity of lymphocytes to secrete interferon‐γ. Among a number of serum inflammatory markers tested, high‐sensitivity‐C‐reactive protein significantly decreased by 37% (p < 0.01) and soluble E‐selectin decreased by 16.6% (p < 0.05).Conclusion: These data suggest a reduced tendency for monocyte/macrophage‐driven inflammation with periodontal therapy and a potential impact on atherosclerosis‐related complications in diabetic individuals.
- 19 April 2007
- Published by Wiley in Journal of Periodontal Research
- Vol. 42 (3) , 274-282
Effects of periodontal therapy on serum C‐reactive protein, sE‐selectin, and tumor necrosis factor‐α secretion by peripheral blood‐derived macrophages in diabetes. A pilot study
Background and Objective: Diabetes is associated with an increased risk for vascular disease and periodontitis. The aim of this study was to assess the effects of periodontal treatment in diabetes with respect to alterations in the pro‐inflammatory potential of peripheral blood mononuclear cells.Material and Methods: Ten patients with diabetes and moderate to severe periodontitis received full‐mouth subgingival debridement. Blood samples for serum/plasma and mononuclear cell isolation were collected prior to and 4 wk after therapy. Mononuclear cells were analyzed by flow cytometry and stimulated with lipopolysaccharide or ionomycin/phorbol ester to determine the pro‐inflammatory capacity of macrophages and lymphocytes, respectively.Results: Following periodontal treatment, all patients demonstrated a significant improvement in clinical periodontal status (p < 0.05), despite only modest reduction in subgingival bacterial load or homologous serum immunoglobulin G titers. CD14+ blood monocytes decreased by 47% (p < 0.05), and the percentage of macrophages spontaneously releasing tumor necrosis factor‐α decreased by 78% (p < 0.05). There were no significant changes in the capacity of lymphocytes to secrete interferon‐γ. Among a number of serum inflammatory markers tested, high‐sensitivity‐C‐reactive protein significantly decreased by 37% (p < 0.01) and soluble E‐selectin decreased by 16.6% (p < 0.05).Conclusion: These data suggest a reduced tendency for monocyte/macrophage‐driven inflammation with periodontal therapy and a potential impact on atherosclerosis‐related complications in diabetic individuals.